BioLASCO Taiwan Co., Ltd. (6662.TWO)
TWD 33.2
(0.3%)
TWD 33.2
(0.3%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 49.74 Million TWD | 17.57% |
| 2022 | 42.31 Million TWD | -6.29% |
| 2021 | 45.15 Million TWD | -28.1% |
| 2020 | 62.8 Million TWD | 14.24% |
| 2019 | 54.97 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 9.07 Million TWD | 157.64% |
| 2024 Q1 | 3.52 Million TWD | -80.22% |
| 2023 Q4 | 17.8 Million TWD | 58.74% |
| 2023 FY | 49.74 Million TWD | 17.57% |
| 2023 Q3 | 11.21 Million TWD | -18.99% |
| 2023 Q2 | 13.84 Million TWD | 101.7% |
| 2023 Q1 | 6.86 Million TWD | -45.3% |
| 2022 FY | 42.31 Million TWD | -6.29% |
| 2022 Q4 | 12.55 Million TWD | 0.0% |
| 2021 FY | 45.15 Million TWD | -28.1% |
| 2020 FY | 62.8 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 80.183% |
| Level Biotechnology Inc. | 62.9 Million TWD | 20.924% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 190.378% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 176.948% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 125.534% |
| GlycoNex Incorporation | -178.36 Million TWD | 127.889% |
| VBI | -6.6 Million TWD | 853.568% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 129.917% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 565.671% |
| Visgeneer Inc. | -19.58 Million TWD | 353.933% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 107.285% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 92.05% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 31.294% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 104.289% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | 922.606% |
| Enimmune corporation | -223.74 Million TWD | 122.232% |
| TaiRx, Inc. | -212.29 Million TWD | 123.431% |
| CHO Pharma, Inc. | -306.08 Million TWD | 116.251% |
| EirGenix Inc. | -915.2 Million TWD | 105.435% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 178.558% |
| Lin BioScience, Inc. | -687.19 Million TWD | 107.239% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 131.82% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | -118.248% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 167.876% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 205.047% |
| RBC Bioscience Corporation | 6.43 Million TWD | -673.608% |
| BiOptic Inc. | 37.74 Million TWD | -31.78% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 107.23% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 233.844% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 180.83% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 81.9% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 196.062% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 230.313% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 129.597% |
| Neith Corporation | -40.03 Million TWD | 224.255% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 154.004% |
| NaviFUS Corp. | -65.72 Million TWD | 175.679% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 156.469% |
| Sinew Pharma Inc. | -170.92 Million TWD | 129.103% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 172.981% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 61.931% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 120.897% |
| AP Biosciences Inc | -339.29 Million TWD | 114.661% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 108.862% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 185.836% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | -488.257% |
| Intech Biopharm Corporation | -337.98 Million TWD | 114.717% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 103.789% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 196.377% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 129.143% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 90.778% |
| TCI GENE Inc. | 11.67 Million TWD | -326.137% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 138.999% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 116.788% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 122.869% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | -391.532% |
| PharmaEngine, Inc. | 274.65 Million TWD | 81.889% |
| Savior Lifetec Corporation | 30.03 Million TWD | -65.644% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 63.62% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 104.753% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 139.685% |
| Acepodia, Inc. | -817.31 Million TWD | 106.086% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 110.184% |